Search

everythinglearnresearchcommunity

for

Search:↓

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

DDAIP-HCl significantly increases minoxidil absorption into the skin.

Combining low-dose dutasteride with finasteride improved a man's hair loss.

New drug dutasteride effectively treats hair loss, but use cautiously due to potential sexual side effects.

Men with early-onset hair loss are less responsive to bromocriptine's heart and metabolism benefits.

New drug uses show promise but need more research.

Dauricine may help treat certain brain cancers by reducing cancer cell growth and promoting cell death.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

Some dibenzo compounds might help treat cancer with fewer side effects.

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

TA-Ado effectively promotes hair growth and reduces hair loss.

New treatments for hair loss focus on targeting specific causes to improve effectiveness and safety.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

A new compound may treat benign prostatic hyperplasia better than finasteride.

Finasteride boosts morphine's pain relief, stops tolerance, and reduces withdrawal in rats.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

Potassium channel openers like minoxidil boost hair growth.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

A new genetic disorder caused by an ODC1 mutation can be treated with DFMO.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

Dissolving microneedles can effectively deliver dutasteride for hair loss treatment.